MENU
last data update: 2011/10/20, 07:12
Website loading time
during the test: 3.84 s
cable connection (average): 3.99 s
DSL connection (average): 4.13 s
modem (average): 11.85 s
HTTP headers
HTTP/1.1 301 Moved Permanently
Content-Type: text/html; charset=UTF-8
Location: http://www.pharmaasia.com/
Server: Microsoft-IIS/7.0
X-Powered-By: ASP.NET
Date: Thu, 20 Oct 2011 14:12:14 GMT
Connection: close
Content-Length: 149
HTTP/1.1 200 OK
Cache-Control: no-cache
Pragma: no-cache,no-cache
Content-Length: 57429
Content-Type: text/html; Charset=utf-8
Expires: Wed, 19 Oct 2011 14:12:14 GMT
Server: Microsoft-IIS/7.0
Set-Cookie: ASPSESSIONIDSQCDDBRT=OFDPDLIDEGPDLLFEHJAPGELN; path=/
X-Powered-By: ASP.NET
Date: Thu, 20 Oct 2011 14:12:16 GMT
Connection: close
Information about DNS servers
pharmaasia.com | A | 120.136.46.142 | IN | 43200 | |
pharmaasia.com | SOA | ns.rackspace.com.pharmaasia.com | hostmaster.rackspace.com.pharmaasia.com | 1269151797 | 3600 300 1814400 300 IN 300 |
pharmaasia.com | NS | ns2.rackspace.com | IN | 43200 | |
pharmaasia.com | NS | ns.rackspace.com | IN | 43200 |
Received from the first DNS server
Request to the server "pharmaasia.com"
You used the following DNS server:
DNS Name: ns2.rackspace.com
DNS Server Address: 65.61.188.4#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 30792
flag: qr aa rd REQUEST: 1, ANSWER: 4, AUTHORITY: 0, ADDITIONAL: 0
REQUEST SECTION:
pharmaasia.com. IN ANY
ANSWER SECTION:
pharmaasia.com. 300 IN SOA ns.rackspace.com.pharmaasia.com. hostmaster.rackspace.com.pharmaasia.com. 1269151797 3600 300 1814400 300
pharmaasia.com. 86400 IN NS ns.rackspace.com.
pharmaasia.com. 86400 IN NS ns2.rackspace.com.
pharmaasia.com. 86400 IN A 120.136.46.142
Received 157 bytes from address 65.61.188.4#53 in 14 ms
Received from the second DNS server
Request to the server "pharmaasia.com"
You used the following DNS server:
DNS Name: ns.rackspace.com
DNS Server Address: 69.20.95.4#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 37978
flag: qr aa rd REQUEST: 1, ANSWER: 4, AUTHORITY: 0, ADDITIONAL: 0
REQUEST SECTION:
pharmaasia.com. IN ANY
ANSWER SECTION:
pharmaasia.com. 300 IN SOA ns.rackspace.com.pharmaasia.com. hostmaster.rackspace.com.pharmaasia.com. 1269151797 3600 300 1814400 300
pharmaasia.com. 86400 IN NS ns.rackspace.com.
pharmaasia.com. 86400 IN NS ns2.rackspace.com.
pharmaasia.com. 86400 IN A 120.136.46.142
Received 157 bytes from address 69.20.95.4#53 in 14 ms
Subdomains (the first 50)
Typos (misspells)
oharmaasia.com lharmaasia.com -harmaasia.com 0harmaasia.com pgarmaasia.com pbarmaasia.com pnarmaasia.com pjarmaasia.com puarmaasia.com pyarmaasia.com phzrmaasia.com phsrmaasia.com phwrmaasia.com phqrmaasia.com phaemaasia.com phadmaasia.com phafmaasia.com phatmaasia.com pha5maasia.com pha4maasia.com pharnaasia.com pharkaasia.com pharjaasia.com pharmzasia.com pharmsasia.com pharmwasia.com | pharmqasia.com pharmazsia.com pharmassia.com pharmawsia.com pharmaqsia.com pharmaaaia.com pharmaazia.com pharmaaxia.com pharmaadia.com pharmaaeia.com pharmaawia.com pharmaasua.com pharmaasja.com pharmaaska.com pharmaasoa.com pharmaas9a.com pharmaas8a.com pharmaasiz.com pharmaasis.com pharmaasiw.com pharmaasiq.com harmaasia.com parmaasia.com phrmaasia.com phamaasia.com pharaasia.com | pharmasia.com pharmasia.com pharmaaia.com pharmaasa.com pharmaasi.com hparmaasia.com pahrmaasia.com phramaasia.com phamraasia.com pharamasia.com pharmaasia.com pharmasaia.com pharmaaisa.com pharmaasai.com ppharmaasia.com phharmaasia.com phaarmaasia.com pharrmaasia.com pharmmaasia.com pharmaaasia.com pharmaaasia.com pharmaassia.com pharmaasiia.com pharmaasiaa.com |
Location
IP: 120.136.46.142
continent: AS, country: Hong Kong (HKG), city:
Website value
rank in the traffic statistics:
There is not enough data to estimate website value.
Basic information
website build using CSS
code weight: 56.08 KB
text per all code ratio: 46 %
title: Drug Manufacturing, Drug Delivery, Clinical Trials News | PharmaAsia
description:
keywords:
encoding: utf-8
language: en
Website code analysis
one word phrases repeated minimum three times
Phrase | Quantity |
---|---|
Oct | 11 |
in | 10 |
and | 6 |
appoints | 6 |
of | 6 |
for | 5 |
to | 4 |
Emerging | 3 |
AMRI | 3 |
Markets | 3 |
as | 3 |
BeiGene | 3 |
acquire | 3 |
the | 3 |
affairs | 3 |
medical | 3 |
News | 3 |
Takeda | 3 |
research | 3 |
12 | 3 |
President | 3 |
17 | 3 |
boost | 3 |
Pharmaceutical | 3 |
two word phrases repeated minimum three times
Phrase | Quantity |
---|---|
to acquire | 3 |
medical affairs | 3 |
12 Oct | 3 |
17 Oct | 3 |
Emerging Markets | 3 |
three word phrases repeated minimum three times
B tags
U tags
I tags
images
file name | alternative text |
---|---|
100105_PA_600x60.jpg | |
default-img.jpg | Pharmaceutical and biotech companies boost resources in medical affairs affiliates |
DigitalEdition_600x60.gif | Roche signs definitive agreement to acquire Anadys Pharmaceuticals |
DigitalEdition_300x250.gif | Takeda appoints Jostein Davidsen Head of Emerging Markets |
1110_PHA_cover_sm.jpg | ICON appoints Colin Stanley President of DOCS |
img-mwatch.jpg | BeiGene in-licenses two clinical-stage oncology compounds |
banner120x600.gif | AMRI appoints new President, India Operations |
imgad?id=CICAgICAtNSS6AEQfRh9MgibXqOa4vaVJw | September-October 2011 |
110622_PHA_WorldDrugDelivery_125x125.gif | Special Report |
110718_VacChina2011_125x125.gif | Dr Reddy |
101203_PHA_LabAsia_125x125.jpg | House Ad |
110912_BioMfg_125x125.gif | Logo |
110824_GAS_125x125.gif | Ten Alps Asia |
110912_BioThe_125x125.gif | |
110725_LogiPharma_125x125.png | |
110823_Downstream_125x125.gif | |
drreddy_logo.jpg | |
DigitalEdition_728x90.gif | |
house-ad.jpg | |
logo.gif | |
tac-logo-ftr.gif | |
tac-logo.gif |
headers
H1
H2
Pharmaceutical and biotech companies boost resources in medical affairs affiliates
Roche signs definitive agreement to acquire Anadys Pharmaceuticals
Takeda appoints Jostein Davidsen Head of Emerging Markets
ICON appoints Colin Stanley President of DOCS
BeiGene in-licenses two clinical-stage oncology compounds
AMRI appoints new President, India Operations
Latest News
On PharmaAsia
Popular Tags
Follow us on PharmaAsia
Current IssueSeptember-October 2011
Special Report
Whitepapers / Press Releases
Editor's Choice
Trending Topics
ICON
international liver cancer congress
BioAlliance
AllCells
Biogen
Quintiles
A*STAR
Agilent
Internet Explorer 6 Detected Close
H3
Pharmaceutical and biotech companies boost resources in medical affairs affiliates
Roche signs definitive agreement to acquire Anadys Pharmaceuticals
Takeda appoints Jostein Davidsen Head of Emerging Markets
ICON appoints Colin Stanley President of DOCS
BeiGene in-licenses two clinical-stage oncology compounds
AMRI appoints new President, India Operations
Latest News
On PharmaAsia
Popular Tags
Follow us on PharmaAsia
Current IssueSeptember-October 2011
Special Report
Whitepapers / Press Releases
Editor's Choice
Trending Topics
ICON
international liver cancer congress
BioAlliance
AllCells
Biogen
Quintiles
A*STAR
Agilent
Internet Explorer 6 Detected Close
H4
Something interesting to share?
Ten Alps Communications Asia Interactive Network
H5
H6
internal links
address | anchor text |
---|---|
/article/pharmaceutical-and-biotech-companies-boost-resources-in-medical-affairs-affiliates/9248 | Pharmaceutical and biotech companies boost resources in medical affairs affiliates |
/article/roche-signs-definitive-agreement-to-acquire-anadys-pharmaceuticals/9243 | Roche signs definitive agreement to acquire Anadys Pharmaceuticals |
/article/takeda-appoints-jostein-davidsen-head-of-emerging-markets/9244 | Takeda appoints Jostein Davidsen Head of Emerging Markets |
/article/icon-appoints-colin-stanley-president-of-docs/9245 | ICON appoints Colin Stanley President of DOCS |
/article/beigene-in-licenses-two-clinical-stage-oncology-compounds/9246 | BeiGene in-licenses two clinical-stage oncology compounds |
/article/amri-appoints-new-president-india-operations/9249 | AMRI appoints new President, India Operations |
/article/pharmaceutical-and-biotech-companies-boost-resources-in-medical-affairs-affiliates/9248 | Pharmaceutical and biotech companies boost resources in medical affairs affiliates |
/article/icon-appoints-colin-stanley-president-of-docs/9245 | ICON appoints Colin Stanley President of DOCS |
/article/takeda-appoints-jostein-davidsen-head-of-emerging-markets/9244 | Takeda appoints Jostein Davidsen Head of Emerging Markets |
/article/roche-signs-definitive-agreement-to-acquire-anadys-pharmaceuticals/9243 | Roche signs definitive agreement to acquire Anadys Pharmaceuticals |
/article/beigene-in-licenses-two-clinical-stage-oncology-compounds/9246 | BeiGene in-licenses two clinical-stage oncology compounds |
/article/amri-appoints-new-president-india-operations/9249 | AMRI appoints new President, India Operations |
/article/nuvilex-s-affiliate-presents-cell-in-a-box-technology-in-seoul/9247 | Nuvilex’s affiliate presents Cell in a Box technology in Seoul |
/article/progenra-and-ono-pharmaceutical-enter-into-research-collaboration/9250 | Progenra and Ono Pharmaceutical enter into research collaboration |
/article/agilent-technologies-supports-research-at-the-broad-institute/9242 | Agilent Technologies supports research at the Broad Institute |
/article/launch-of-biolynx-provides-a-boost-for-the-international-malaria-research-community/9241 | Launch of BioLynx provides a boost for the international malaria research community |
/article/bristol-myers-squibb-foundation-announces-collaboration-with-who-s-stop-tb-department/9240 | Bristol-Myers Squibb Foundation announces collaboration with WHO’s Stop TB Department |
/category/latest-news/1 | More News |
#tab1_1 | Most Read |
#tab1_2 | Press Releases |
#tab1_3 | Whitepapers |
/article/pharma-logistics-supplement-asian-potential/8358 | Pharma Logistics Supplement: Asian Potential |
/article/agilent-technologies-and-chungnam-national-university-collaborate-to-further-glycomics-research/9190 | Agilent Technologies and Chungnam National University collaborate to further glycomics research |
/article/bristol-myers-squibb-completes-acquisition-of-amira-pharmaceuticals/9210 | Bristol-Myers Squibb completes acquisition of Amira Pharmaceuticals |
/article/puracyp-and-promega-combine-cell-lines-and-assay-systems/9204 | Puracyp and Promega combine cell lines and assay systems |
/article/dr-reddy-starts-phase-2-study-with-cetp-inhibitor-in-dyslipidemia-patients/9205 | Dr Reddy's starts phase 2 study with CETP inhibitor in dyslipidemia patients |
/article/icon-selected-as-provider-for-early-phase-clinical-development-by-bms/9199 | ICON selected as provider for early phase clinical development by BMS |
/article/ge-healthcare-to-invest-us-1-billion-in-new-oncology-solutions/9217 | GE Healthcare to invest US$1 billion in new oncology solutions |
/article/boehringer-ingelheim-licenses-probiogen-glymaxx-technology/9179 | Boehringer Ingelheim licenses ProBioGen's GlymaxX technology |
# | More Most Viewed |
/article/pharmaceutical-and-biotech-companies-boost-resources-in-medical-affairs-affiliates/9248 | Pharmaceutical and biotech companies boost resources in medical affairs affiliates |
/article/roche-signs-definitive-agreement-to-acquire-anadys-pharmaceuticals/9243 | Roche signs definitive agreement to acquire Anadys Pharmaceuticals |
/article/takeda-appoints-jostein-davidsen-head-of-emerging-markets/9244 | Takeda appoints Jostein Davidsen Head of Emerging Markets |
/article/icon-appoints-colin-stanley-president-of-docs/9245 | ICON appoints Colin Stanley President of DOCS |
/article/beigene-in-licenses-two-clinical-stage-oncology-compounds/9246 | BeiGene in-licenses two clinical-stage oncology compounds |
/article/amri-appoints-new-president-india-operations/9249 | AMRI appoints new President, India Operations |
mailto:raymond.foo@tenalpsasia.com?to=raymond.foo@tenalpsasia.com&subject=Press Release Contribution | Submit Your Press Release To Us |
mailto:raymond.foo@tenalpsasia.com?to=raymond.foo@tenalpsasia.com&subject=Whitepaper Contribution | Submit Your Whitepaper To Us |
/tag/ICON/1 | ICON |
/tag/international-liver-cancer-congress/1 | international liver cancer congress |
/tag/BioAlliance/1 | BioAlliance |
/tag/AllCells/1 | AllCells |
/tag/Biogen/1 | Biogen |
/tag/Quintiles/1 | Quintiles |
/tag/A*STAR/1 | A*STAR |
/tag/Agilent/1 | Agilent |
/tag/Abbott/1 | Abbott |
/tag/Promega/1 | Promega |
/tag/Puracyp/1 | Puracyp |
/tag/Drug-Discovery/1 | Drug Discovery |
http://www.pharmaasia.com/ebook/1110.asp | Download eBook |
/article/from-cancer-research-to-innovative-applications-the-dutch-revolution/9158 | From cancer research to innovative applications: The Dutch revolution |
/article/strength-to-strength/9033 | Strength to strength |
/article/api-china-interphex-china-autumn-2010-bringing-the-world-closer/8869 | API China, Interphex China Autumn 2010: Bringing the world closer |
mailto:raymond.foo@tenalpsasia.com?to=raymond.foo@tenalpsasia.com&subject=Whitepapers / PR Contribution | Send it to us! |
# | Editor's Choice |
/article/dr-reddy-starts-phase-2-study-with-cetp-inhibitor-in-dyslipidemia-patients/9205 | Dr Reddy |
/article/dr-reddy-starts-phase-2-study-with-cetp-inhibitor-in-dyslipidemia-patients/9205 | Dr Reddy's starts phase 2 study with CETP inhibitor in dyslipidemia patients |
/article/allcells-expands-operations-in-shanghai-china/9203 | AllCells expands operations in Shanghai, China |
/article/abbott-receives-fda-approval-for-alk-gene-test-for-lung-cancer-therapy-selection/9197 | Abbott receives FDA approval for ALK gene test for lung cancer therapy selection |
/article/paromomycin-added-to-national-essential-medicines-list-by-government-of-nepal/9187 | Paromomycin added to national essential medicines list by government of Nepal |
/article/pharmacovigilance-at-the-intersection-of-healthcare-and-life-sciences/9152 | Pharmacovigilance: At the intersection of healthcare and life sciences |
/article/vasolan-receives-approval-for-atrial-fibrillation-flutter-and-paroxysmal-supraventricular-tachycardia/6826 | Vasolan Receives Approval for Atrial Fibrillation/Flutter and Paroxysmal Supraventricular Tachycardia |
javascript:void{0} | |
javascript:void{0} | |
/tag/ICON/1 | ICON |
/article/icon-appoints-colin-stanley-president-of-docs/9245 | ICON appoints Colin Stanley President of DOCS |
/article/icon-selected-as-provider-for-early-phase-clinical-development-by-bms/9199 | ICON selected as provider for early phase clinical development by BMS |
/article/icon-appoints-president-of-early-phase-division/9183 | ICON appoints President of Early Phase Division |
/article/icon-announces-asia-pacific-seminar-series/9072 | ICON announces Asia Pacific seminar series |
/article/icon-pfizer-announce-strategic-partnership-for-clinical-r-d/9026 | ICON, Pfizer announce strategic partnership for clinical R&D |
/tag/international-liver-cancer-congress/1 | international liver cancer congress |
/article/bioalliance-pharma-presents-orphan-drug-survival-results-at-international-liver-cancer-congress/9206 | BioAlliance Pharma presents orphan drug survival results at international liver cancer congress |
/tag/BioAlliance/1 | BioAlliance |
/article/bioalliance-pharma-presents-orphan-drug-survival-results-at-international-liver-cancer-congress/9206 | BioAlliance Pharma presents orphan drug survival results at international liver cancer congress |
/article/bioalliance-pharma-complements-its-portfolio-with-a-european-licence-for-ondansetron-rapidfilm/7120 | BioAlliance Pharma complements its portfolio with a European licence for ondansetron RapidFilm |
/article/bioalliance-acquires-european-rights-for-ondansetron-oral-spray/6979 | BioAlliance acquires European Rights for Ondansetron Oral Spray |
/tag/AllCells/1 | AllCells |
/article/allcells-expands-operations-in-shanghai-china/9203 | AllCells expands operations in Shanghai, China |
/tag/Biogen/1 | Biogen |
/article/boehringer-ingelheim-licenses-probiogen-glymaxx-technology/9179 | Boehringer Ingelheim licenses ProBioGen's GlymaxX technology |
/article/biogen-idec-abbott-report-positive-results-from-trial-of-daclizumab-hyp/9150 | Biogen Idec, Abbott report positive results from trial of daclizumab HYP |
/article/biogen-idec-identify-novel-approach-for-treatment-of-multiple-sclerosis/9097 | Biogen Idec identify novel approach for treatment of multiple sclerosis |
/article/biogen-idec-identify-novel-approach-for-treatment-of-multiple-sclerosis/9169 | Biogen Idec identify novel approach for treatment of multiple sclerosis |
/article/biogen-idec-celebrates-world-ms-day/9022 | Biogen Idec celebrates World MS Day |
/tag/Quintiles/1 | Quintiles |
/article/quintiles-find-innovation-is-vital-to-future-of-biopharma/9115 | Quintiles find innovation is vital to future of biopharma |
/article/konect-quintiles-partner-to-advance-clinical-research-education/9052 | KoNECT, Quintiles partner to advance clinical research education |
/article/quintiles-opens-global-service-operations-center-in-india/8766 | Quintiles opens global service operations center in India |
/article/quintiles-in-partnership-with-university-of-malaya/8477 | Quintiles in partnership with University of Malaya |
/article/quintiles-launches-tissue-testing-services-in-china/8265 | Quintiles Launches Tissue Testing Services In China |
/tag/A*STAR/1 | A*STAR |
/article/a-star-simtech-launches-microfluidics-foundry/9221 | A*STAR SIMTech launches microfluidics foundry |
/article/agilent-and-a-star-launch-drug-screening-platform-in-singapore/9125 | Agilent and A*STAR launch drug screening platform in Singapore |
/article/agilent-and-a-star-launch-drug-screening-platform-in-singapore/9165 | Agilent and A*STAR launch drug screening platform in Singapore |
/article/a-star-scientists-make-breakthroughs-against-cancer/8569 | A*Star scientists make breakthroughs against cancer |
/article/detecting-dna-the-electrochemical-way/7403 | Detecting DNA the Electrochemical Way |
/tag/Agilent/1 | Agilent |
/article/agilent-technologies-supports-research-at-the-broad-institute/9242 | Agilent Technologies supports research at the Broad Institute |
/article/agilent-technologies-lc-ms-manufacturing-achieves-iso-13485-certification/9208 | Agilent Technologies’ LC/MS manufacturing achieves ISO 13485 certification |
/article/agilent-technologies-and-chungnam-national-university-collaborate-to-further-glycomics-research/9190 | Agilent Technologies and Chungnam National University collaborate to further glycomics research |
/article/agilent-and-a-star-launch-drug-screening-platform-in-singapore/9125 | Agilent and A*STAR launch drug screening platform in Singapore |
/article/agilent-and-a-star-launch-drug-screening-platform-in-singapore/9165 | Agilent and A*STAR launch drug screening platform in Singapore |
/ | Logo |
# | Hot Topics |
# | air to china |
# | australia freight |
# | china forwarders |
/ | Home |
/category/latest-news/1 | Latest News |
javascript:void(0); | Categories |
/category/drug-discovery/1 | Drug Discovery |
/category/drug-development/1 | Drug Development |
/category/drug-manufacturing/1 | Drug Manufacturing |
/category/drug-delivery/1 | Drug Delivery |
/category/clinical-trials/1 | Clinical Trials |
/category/alliances-and-mergers/1 | Alliances and Mergers |
/category/qa-qc-and-compliance/1 | QA/QC and Compliance |
/category/pharmaceutical-processing-and-packaging/1 | Pharmaceutical Processing and Packaging |
/eventcalendar | Event Calendar |
/directorylisting//1 | |
javascript:void(0); | more |
/archive/2011/0 | Magazine Archives |
/rssfeeds | RSS Feeds |
/aboutus | About Pharma Asia |
/contactus | Contact Us |
/documents/PharmaAsia Media Kit 2011.pdf | Media Kit |
http://www.pharmaasia.com | Drug Manufacturing, Drug Delivery, Clinical Trials |
# | Terms and Conditions of Use |
# | Privacy Policy |
/signin | Sign In |
/register | Register |
javascript:void(0); | About Us |
#none | Bookmark This Page |
javascript:void(0) | Skip, no thanks |
external links
address | anchor text |
---|---|
http://www.taca-subn.com/pharmaasia/ | img |
http://www.taca-subn.com/pharmaasia/ | img |
http://www.taca-subn.com/pharmaasia/ | img |
http://www.taca-subn.com/pharmaasia/pharma_form.htm | img |
http://googleads.g.doubleclick.net/aclk?sa=L&ai=BGOUGi8hxToq7K4eh8AOCodmBCezUm5QCAAAAEAEg8qqNEzgAUPKEwqUHWKy2r-0hYL-N9AWyARJ3d3cucGhhcm1hYXNpYS5jb226AQlnZnBfaW1hZ2XIAQPaARpodHRwOi8vd3d3LnBoYXJtYWFzaWEuY29tL-ABBpgC6AfAAgLgAgDqAg1QSEFfMTI1eDEyNV8x-ALw0R6QA7AJmAOwCagDAeAEAaAGFA&num=0&sig=AOD64_1RuSYwXFmCQkEtDp1CC-lYTu_4RQ&client=ca-pub-1051597459337710&adurl=http://www.clinicaltrialsupplyasia.com/Event.aspx%3Fid%3D560682%26MAC%3DISG_PHA_BA | img |
http://www.imapac.com/index.php?page=world-drug-delivery-congress-2011 | img |
http://vac.globaleaders.com/ | img |
http://www.lab-asia.com | img |
http://www.imapac.com/index.php?page=biomanufacturingworld2011 | img |
http://www.generics-asia.com | img |
http://www.imapac.com/index.php?page=biotherapeuticsworld2011 | img |
http://www.wbresearch.com/logipharmaasia/.aspx?utm_campaign=MP&utm_medium=MPDL&utm_source=SGExt&utm_content=Homepage&MAC=TAA_LPA11 | img |
http://www.downstreambioprocessing.com/Event.aspx?id=583466&MAC=PAba | img |
http://www.taca-subn.com/pharmaasia/ | img |
http://www.taca-subn.com/pharmaasia/ | House Ad |
http://www.taca-subn.com/pharmaasia/ | Subscription |
http://www.asiafoodjournal.com | Food Processing, Food Packaging, Ingredients |
http://www.ceasiamag.com | Control Systems, Process Instruments, Motors and Drives |
http://www.emasiamag.com | PCB Production, Microelectronics Components, Surface Mounting |
http://www.emasia-china.com | Electronics Manufacturing China |
http://www.logasiamag.com | Logistics Management, Supply Chain, Warehouse Management |
http://www.payloadasia.com | Air Cargo Carriers and Terminals, Freight Forwarders, Airports |
http://www.onscreenasia.com/indexai.asp | Broadcasting, Post-Production, Digital Animation |
http://www.onscreenasia.com/indextva.asp | IPTV, Cable TV, TV Advertising |
http://www.asiantvawards.com | Asian Television Awards |
http://www.onscreenasia.com | OnScreenAsia |
http://www.travelweeklyweb.com | Tourism, Hotels, Aviation, Travel Agents, MICE |
http://www.travelweekly-china.com | TravelWeekly China |
http://www.tenalpsasia.com/ | Ten Alps Communications Asia. |
http://www.tenalpsasia.com/category.php?cid=51 | About Ten Alps Asia |
http://www.tenalpsasia.com/catimg.php?cid=100 | Our Publications |
http://www.tenalpsasia.com/locations.php?cid=54 | Our Locations |
http://www.microsoft.com/download/en/details.aspx?id=43 | |
http://www.mozilla.com/en-US/firefox/new/ | |
http://www.google.com/chrome | |
http://www.apple.com/safari/ |